| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 40.804 | 9 |
| GSM780708 | Untreated after 4 days (C2_1) | 43.117 | 18 |
| GSM780709 | Untreated after 4 days (C3_1) | 41.3753 | 11 |
| GSM780719 | Untreated after 4 days (C1_2) | 44.8886 | 27 |
| GSM780720 | Untreated after 4 days (C2_2) | 45.4564 | 29 |
| GSM780721 | Untreated after 4 days (C3_2) | 40.1971 | 7 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 43.4584 | 20 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 44.9648 | 27 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 39.5644 | 5 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 48.081 | 41 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 48.6654 | 44 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 50.0243 | 49 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 40.6193 | 8 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 45.6712 | 30 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 46.0476 | 32 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 43.5193 | 20 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 48.3496 | 43 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 42.3872 | 15 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 45.7156 | 31 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 50.4653 | 50 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 42.6745 | 16 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 48.9501 | 45 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 49.1736 | 46 |